Endokrine Aspekte des Hochdrucks

  • Hans Vetter
  • Wilhelm Vetter


Um die Jahrhundertwende erzeugten Tigerstedt und Bergman einen Hochdruck bei Hunden durch Injektion eines Nierenextrakts, welchen sie Renin nannten [176]. Jahrzehnte später gelang es Goldblatt et al. in seinen klassischen Experimenten, einen Zusammenhang zwischen experimentell erzeugter Stenosierung der Nierenarterie und Hypertonie nachzuweisen [78].


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aiken JW, Vane JR (1970) The renin-angioten- sin system: inhibition of converting enzyme in isolated tissues. Nature 228:30–34PubMedCrossRefGoogle Scholar
  2. 2.
    Aitchison J, Brown JJ, Ferris JB, Fräser R, Kay AW, Lever AF, Neville AM, Symington T, Robertson JIS (1971) Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin activity. Am Heart J 82:660–671PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson RC, Herbert PN, Mulrow PJ (1968) A comparison of properties of renin obtained from the kidney and uterus of the rabbit. Am J Physiol 215:774–778PubMedGoogle Scholar
  4. 4.
    Armbruster H, Vetter W, Beckerhoff R, Nußberger J, Vetter H, Siegenthaler W (1975) Diurnal variations of plasma aldosterone in supine man: Relationship to plasma renin activity and plasma Cortisol. Acta Endocrinol (Kbh) 80: 95–103Google Scholar
  5. 5.
    Armbruster H, Vetter W, Reck G, Beckerhoff R, Siegenthaler W (1975) Severe arterial hypertension caused by chronical abuse of a topical mineralocorticoid. Int J Clin Pharmacol Bio- pharm 12:170–173Google Scholar
  6. 6.
    Baer LB, Sommers SC, Krakoff LR, Newton MA, Laragh JH (1970) Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism. Circ Res (Suppl 1) 26–27:203–219Google Scholar
  7. 7.
    Bakkle YS (1971) Inhibition of angiotensin I converting enzyme by venom peptides. Br J Pharmacol 43:252–254Google Scholar
  8. 8.
    Bamett IG (1970) Fluctuating Cushing’s syndrome, acute psychosis, aminoglutethimide therapy. Proc R Soc Med 63:338–339Google Scholar
  9. 9.
    Baron JH, Nabarro JDN, Slater KDH, Tuffley R (1969) Metabolie studies, aldosterone secretion rate, and plasma renin after carbenoxolone sodium. Br Med J 2:793–795PubMedCrossRefGoogle Scholar
  10. 10.
    Bassøe HH, Emberland R, Støa KF (1958) Fluctuating steroid excretion in Cushing’s syndrome. Acta Endocrinol (Kbh) 28:163–168Google Scholar
  11. 11.
    Bayard F, Cooke CR, Tiller DJ, Beitins IZ, Kowarski A, Walter WG, Migeon CJ (1971) The regulation of aldosterone secretion in anephric man. J Clin Invest 50:1585–1595PubMedCrossRefGoogle Scholar
  12. 12.
    Bayliss RIS, Edwards OM, Starer F (1970) Complications of adrenal venography. Br J Radiol 43:531–533PubMedCrossRefGoogle Scholar
  13. 13.
    Beevers DG, Brown JJ, Ferris JB, Eraser R, Lever AF, Robertson JIS, Tree M (1976) Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism. Q J Med 45:401–410PubMedGoogle Scholar
  14. 14.
    Biglieri EG, Herron MA, Brust N (1966) 17- Hydroxylation deficiency in man. J Clin Invest 45:1946–1954PubMedCrossRefGoogle Scholar
  15. 15.
    Biglieri EG, Schambelan M, Brust N, Chang B, Hogan M (1974) Plasma aldosterone concentration, further characterization of aldosterone- producing adenomas. Circ Res (Suppl 1) 34–35:183–189Google Scholar
  16. 16.
    Biglieri EG, Schambelan M, Slaton PE (1969) Effect of adrenocorticotropin on desoxycorti- costerone, corticosterone and aldosterone excretion. J Clin Endocrinol Metab 29: 1090–1101PubMedCrossRefGoogle Scholar
  17. 17.
    Biglieri EG, Stockigt JR, Schambelan M (1970) A preliminary evaluation for primary aldosteronism. Arch Intern Med 126:1004–1007PubMedCrossRefGoogle Scholar
  18. 18.
    Biglieri EG, Stockigt JR, Schambelan M (1979) Adrenal mineralocorticoids causing hypertension. Am J Med 52:623–632CrossRefGoogle Scholar
  19. 19.
    Birke G, Diczfalusy E, Plantin LO (1956) Fluctuation in the excretion of adrenocortical steroids in a case of Cushing’s syndrome. J Clin Endocrinol Metab 16:286–290PubMedCrossRefGoogle Scholar
  20. 20.
    Biron P, Huggins CG (1968) Pubnonary activation of synthetic angiotensin I. Life Sci 7: 965–970PubMedCrossRefGoogle Scholar
  21. 21.
    Blaine EH, Davis JO, Witty RT (1970) Renin release after hemorrhage and after suprarenal aortic constriction in dogs without sodium delivery to the macula densa. Circ Res 27: 1081–1089PubMedGoogle Scholar
  22. 22.
    Blaine EH, Davis JO, Prewitt RL (1971) Evidence for a renal vascular receptor in control of renin secretion. Am J Physiol 220:1593–1597PubMedGoogle Scholar
  23. 23.
    Blair-West RJ, Beierwaltes WH, Lieberman LM, Boyd CM, Counsell RE, Weinhold PA, Varma VM (1971) Radiolabeled cholesterol as an adrenal scanning agent. J Nucl Med Allied Sci 12:176–182Google Scholar
  24. 24.
    Blair-West JR, Coghlan JP, Denton DA, Funder JW, Scoggins BA, Wright RD (1971) The effect of the heptapeptide (2–8) and hexapep- tide (3–8) fragments of angiotensin II on aldosterone secretion. J CUn Endocrinol Metab 32:575–578CrossRefGoogle Scholar
  25. 25.
    Braun-Menéndez E, Fasciolo JC, Leloir LF, Munoz JM (1940) The substance causing renal hypertension. J Physiol (Lond) 98:283Google Scholar
  26. 26.
    Brooks RV, Jeffcoat SL, London DR, Prunty FTG, Smith PM (1966) Intermittent Cushing’s syndrome with anomalous response to dexame- thasone. J Endocrinol 36:53–61PubMedCrossRefGoogle Scholar
  27. 27.
    Brown JJ, Chinn RH, Davies DL, Düsterdieck G, Raser R, Lever AF, Robertson JIS, Tree A, Wiseman A (1968) Plasma electrolytes, renin and aldosterone in the diagnosis of primary aldosteronism. Lancet II: 55–59CrossRefGoogle Scholar
  28. 28.
    Brown JJ, Davies DL, Ferris JB, Eraser R, Haywood E, Lever AF, Robertson JIS (1972) Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess and low plasma renin. Br Med J 2:729–734PubMedCrossRefGoogle Scholar
  29. 29.
    Brown RD, Loon GR van, Orth DN, Liddle DW (1973) Cushing’s disease with periodic hor- mogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab 36:445–451PubMedCrossRefGoogle Scholar
  30. 30.
    Brubacher ES, Vander AJ (1968) Sodium deprivation and renin secretion in unanesthetized dogs. Am J Physiol 214:15–21PubMedGoogle Scholar
  31. 31.
    Brunner HR, Baer L, Sealey JE, Ledingham JGG, Laragh JH (1970) The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest 49:2128–2138PubMedCrossRefGoogle Scholar
  32. 32.
    Bucht H (1969) Percutaneous catheterisation of the left adrenal vein in man. Scand J Clin Lab Invest (Suppl 64) 14:27–38Google Scholar
  33. 33.
    Bucht H, Bergström J, Lindholmer B, Wijnbladh H, Hökfelt B (1964) Catheterisation of the left adrenal vein for contrast injection and steroid analysis in a case of Conn’s syndrome. Acta Med Scand 176:233–241PubMedCrossRefGoogle Scholar
  34. 34.
    Burton J, Poulsen K, Haber E (1975) Competitive inhibitors of renin: inhibitors effective at physiological. Biochemistry 14:3892–3898PubMedCrossRefGoogle Scholar
  35. 35.
    Cain JP, Tuck ML, Williams GH, Dluhy RG, Rosenoff SH (1972) The regulation of aldosterone secretion in primary aldosteronism. Am J Med 53:627–637PubMedCrossRefGoogle Scholar
  36. 36.
    Cape JP, Wesson LG, Aponte GE (1968) Characterization and source of a renin-like enzyme in anephric humans. J Clin Endocrinol Metab 28:221–230CrossRefGoogle Scholar
  37. 37.
    Carmalt MHB, Dalton GA, Fletcher RF, Smith WT (1977) The treatment of Cushing’s disease by trans-sphenoidal hypophysectomy. Q J Med 46:119–134PubMedGoogle Scholar
  38. 38.
    Carretero OA, Houle JA (1970) A comparison of renin obtained from pregnant uterus and kidney of the dog. Am J Physiol 218:689–692PubMedGoogle Scholar
  39. 39.
    Child DF, Burke CW, Buriey DM, Rees LH, Fraser TR (1970) Drug control of Cushing’s syndrome. Combined aminoglutethimide and metyrapone therapy. Acta Endocrinol (Kbh) 82:330–334Google Scholar
  40. 40.
    Christy NP (1971) Iatrogenic Cushing’s syndrome. In: Christy NP (ed) The human adrenal cortex. Harper & Row, New York, pp 395–425Google Scholar
  41. 41.
    Conn JW (1955) Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45:3–17PubMedGoogle Scholar
  42. 42.
    Conn JW (1967) The evolution of primary aldosteronism 1954–1967. Harvey Lect 62: 257–291Google Scholar
  43. 43.
    Conn JW, Cohen EL, Herwig KR (1976) The dexamethasone-modified adrenal scintiscan in hyporeninemic aldosteronism (tumor versus hyperplasia). A comparison with adrenal venography and adrenal venous aldosterone. J Lab Clin Med 88:841–856PubMedGoogle Scholar
  44. 44.
    Conn JW, Cohen EL, Rovner DR, Nesbit RM (1965) Normokalemic primary aldosteronism. A detectable cause of curable „essential” hypertension. JAMA 193:200–206PubMedCrossRefGoogle Scholar
  45. 45.
    Conn JW, Knopf RF, Nesbit RM (1964) Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 107:159–172PubMedCrossRefGoogle Scholar
  46. 46.
    Conn JW, Rovner DR, Cohen EL (1968) Licorice-induced pseudoaldosteronism. JAMA 205:492–496PubMedCrossRefGoogle Scholar
  47. 47.
    Connolly CK, Gore MBR, Stanley N, Wills MR (1968) Single- dose dexamethasone suppression in normal subjects and in hospital patients. Br Med J 2:665–667PubMedCrossRefGoogle Scholar
  48. 48.
    Cooke CR, Horvath JS, Moore MA, Bledsoe T, Walker WG (1973) Modulation of plasma aldosterone concentration by plasma potassium in anephric man in the absence of a change in potassium balance. J Clin Invest 52:3028–3032PubMedCrossRefGoogle Scholar
  49. 49.
    Cope CL (1956) Diagnostic use of adrenal inhibition in Cushing’s syndrome. Br Med J 2: 193–197PubMedCrossRefGoogle Scholar
  50. 50.
    Crane MG, Harris JJ (1966) Deoxycorticosterone secretion rates in hyperadrenocorticism. J Clin Endocrinol Metab 26:1135–1143PubMedCrossRefGoogle Scholar
  51. 51.
    Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 50:137–195Google Scholar
  52. 52.
    Danforth DN, Oriando MM, Bartter FC, Javadpour N (1977) Renal changes in primary aldosteronism. J Urol 117:140–144PubMedGoogle Scholar
  53. 53.
    David DS, Berkowitz JS (1969) Ocular effects of topical and systemic corticosteroids. Lancet 11:149–151CrossRefGoogle Scholar
  54. 54.
    Davies WW, Newsome HH, Wright LD, Hammond WG, Easton J, Bartter FC (1967) Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity. Am J Med 42:642–647CrossRefGoogle Scholar
  55. 55.
    Davis JO, Urquhart J, Higgins A (1963) The effects of alteration of plasma sodium and potassium concentration on aldosterone secretion. J Clin Invest 42:597–609PubMedCrossRefGoogle Scholar
  56. 56.
    Deller JJ, Wegienka LC, Conte NF, Rosner JM, Forsham PH (1975) Testosterone metabolism in idiopathic hirsutism. Ann Intern Med 63: 369–376Google Scholar
  57. 57.
    Deodhar SD, Haas E, Goldblatt H (1964) Production of antirenin to homologous renin and its effect on experimental renal hypertension. J Exp Med 119:425–432PubMedCrossRefGoogle Scholar
  58. 58.
    Dige-Petersen H, Munkner T, Fogh J, Blichert-Toft M, Lund JO (1975) J-19-iodocholesterol scintigraphy of the adrenal cortex. Acta Endocrinol (Kbh) 80:81–94Google Scholar
  59. 59.
    Distier A, Barth CH, Roscher S, Vescei P, Dhom G, Wolff HP (1969) Hochdruck und Aldosteronismus bei solitären Adenomen und bei nodulärer Hyperplasie der Nebennierenrinde. Klin Wochenschr 47:688–695CrossRefGoogle Scholar
  60. 60.
    Dluhy RG, Axelrod L, Underwood RH, Williams GH (1972) Studies on the control of plasma aldosterone concentration in normal man. IL Effect of dietary potassium and acute potassium infusion. J Clin Invest 51:1950–1957PubMedCrossRefGoogle Scholar
  61. 61.
    Eagan RT, Page MI (1971) Adrenal insufficiency following bilateral adrenal venography. JAMA 215:115–116PubMedCrossRefGoogle Scholar
  62. 62.
    Edelman R, Hartcroft PM (1961) Localization of renin in juxtaglomerular cells of rabbit and dog through the use of the fluorescent- antibody technique. Circ Res 9:1069–1077Google Scholar
  63. 63.
    Ehrüch EN, Dominguez OV, Samuels LT, Lynch D, Oberhelman H, Warner NE (1963) Aldosteronism and precocious puberty due to an ovarian androblastome (sertoli cell tumor). J Clin Endocrinol Metab 23:358–367CrossRefGoogle Scholar
  64. 64.
    Ferreira SH (1965) A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jajaraca. Br J Pharmacol Chemother 24: 163–169PubMedGoogle Scholar
  65. 65.
    Ferris JB, Brown JJ, Fraser R, Haywood E, Davies DL, Kay AW, Lever AF, Robertson JIS, Owen K, Peart WS (1975) Results of adrenal surgery in patients with hypertension, aldosterone excess and low plasma renin concentration. Br Me 1:135–138CrossRefGoogle Scholar
  66. 66.
    Ferris JB, Brown JJ, Fraser R, Kay AW, Neville AM, O’Muircheartaigh IG, Robertson JIS, Symington T, Lever AF (1970) Hypertension with aldosterone excess and low plasma renin: Preoperative distinction between patients with and without adrenocortical tumor. Lancet II: 995–1000CrossRefGoogle Scholar
  67. 67.
    Ferris TF, Gordon P, Mulrow PJ (1967) Rabbit uterus as a source of renin. Am J Physiol 212:698–706PubMedGoogle Scholar
  68. 68.
    Fisher EE, Turner FA, Horton R (1971) Remission of primary hyperaldosteronism after adrenal venography. N Engl J Med 285:334–336PubMedCrossRefGoogle Scholar
  69. 69.
    Fishman LM, Küchel O, Liddle GW, Michelakis AM, Gordon RD, Chick WT (1968) Incidence of primary aldosteronism in uncomcated „essential” hypertension. JAMA 205:497–502PubMedCrossRefGoogle Scholar
  70. 70.
    Flanagan MJ, Monald JH (1967) Heterotopic adrenocortical adenoma producing primary aldosteronism. J Urol 98:133–139PubMedGoogle Scholar
  71. 71.
    Fleisher DS (1967) Pituitary-adrenal responsiveness after corticosteroid therapy in children with nephrosis. J Pediatr 70:54–59PubMedCrossRefGoogle Scholar
  72. 72.
    Forman B, Antar NA, Touloukian RJ, Mulrow PJ, Genel M (1974) Localization of a metastatic adrenal carcinoma using J-19-iodocholeste- rol. J Nucl Med Allied Sci 15:332–334Google Scholar
  73. 73.
    French FS, Macfie JA, Baggett B, Wilhams TF, Wyk J van (1969) Cushing’s syndrome with a paradoxical response to dexamethasone. Am J Med 47:619–624PubMedCrossRefGoogle Scholar
  74. 74.
    Fukuchi S, Takenouchi T, Nakagima K, Watanabe H, Sugita A (1975) Location of aldoster- one-producing adenomas by the determination of plasma aldosterone in adrenal vein or renal vein blood. CH Sci Mol Med 49:187–192Google Scholar
  75. 75.
    Ganguly A, Melada GA, Luetscher JA, Dowdy AJ (1973) Control of plasma aldosterone in primary aldosteronism. Distinction between adenoma and hyperplasia. J Clin Endocrinol Metab 37:765–775PubMedCrossRefGoogle Scholar
  76. 76.
    Ganten D, Márquez-Julio A, Granger P, Hayduk K, Karsunky KP, Boucher R, Genest J (1971) Renin in dog brain. Am J Physiol 221:1733–1737PubMedGoogle Scholar
  77. 77.
    George JM, Wright LW, Bell NH, Bartter FC (1970) The syndrome of primary aldosteronism Am J Med 48:343–356PubMedCrossRefGoogle Scholar
  78. 78.
    Goldblatt H, Lynch J, Hanzal RF, Summerville WW (1934) Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59:347–379PubMedCrossRefGoogle Scholar
  79. 79.
    Goodfriend T, Alhnan D, Kent K, Dempsey P, Cooper T (1971) Angiotensin’s inotropic and mitochondrial effects. Clin Res 19:316Google Scholar
  80. 80.
    Goormaghtigh N (1939) Existence of an endocrine gland in the media of the renal arterioles. Proc Soc Exp Biol Med 42:688–689Google Scholar
  81. 81.
    Granger P, Dahlheim H, Thurau K (1972) Enzyme activities of the single juxtaglomerular apparatus in the rat kidney. Kidney Int 1:78–88PubMedCrossRefGoogle Scholar
  82. 82.
    Greco F del, Dolkart R, Skom J, Method H (1966) Association of accelerated (malignant) hypertension in a patient with primary aldosteronism. J Clin Endocrinol Metab 26: 808–814PubMedCrossRefGoogle Scholar
  83. 83.
    Green JRB, Hoff W van’t (1975) Cushing’s syndrome with fluctuation due to adrenal adenoma. J Clin Endocrinol Metab 41:235–240PubMedCrossRefGoogle Scholar
  84. 84.
    Greminger P, Vetter W, Zimmermann K, Bek- kerhoff R, Siegenthaler W (1977) Primäre und sekundäre Hypertonie in einem poliklinischen Patientengut. Schweiz Med Wochenschr 107:605–609PubMedGoogle Scholar
  85. 85.
    Gross F, Schaechtelin G, Ziegler M, Berger M (1964) A renin-like substance in the placenta and uterus of the rabbit. Lancet 1:914–916PubMedCrossRefGoogle Scholar
  86. 86.
    Gulati PD, Malik GB, Vaishnava H (1973) Al- temate-day steroid therapy in adult nephrotics. J Med 4:266–275PubMedGoogle Scholar
  87. 87.
    Hankin ME, Theile HM, Steinbeck AW (1977) An evaluation of laboratory tests for the detection and differential diagnosis of Cushing’s syndrome. Clin Endocr (Oxford) 6:185–196CrossRefGoogle Scholar
  88. 88.
    Harter JG, Reddy WJ, Thorn GW (1963) Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 269:591–596PubMedCrossRefGoogle Scholar
  89. 89.
    Heiman WG, Freiberger RH (1960) A vascular necrosis of the femoral and humeral heads after high-dosage corticosteroid therapy. N Engl J Med 263:672–675CrossRefGoogle Scholar
  90. 90.
    Helber A, Dvorak K, Winkelmann W, Meurer KA, Würz H, Dickmans A (1975) 131J-Choleste- rin-Szintigraphie der Nebennieren. Erfahrungen bei verschiedenen Nebennierenerkrankungen, insbesondere einseitigen Nebennierentumoren. Dtsch Med Wochenschr 100:2524–2527PubMedCrossRefGoogle Scholar
  91. 91.
    Helhnan L, Weitzmann ED, Roffwarg H, Fukushima DK, Gallagher TF (1970) Cortisol is secreted episodically in Cushing’s syndrome. J Clin Endocrinol Metab 30:686–689CrossRefGoogle Scholar
  92. 92.
    Hoet JJ, Molineaux L (1960) Conn’s syndrome: The effect of amphenone. Acta Endocrinol (Kbh) 33:375–387Google Scholar
  93. 93.
    Hogan MJ, Mae J, Schambelan M, Biglieri EG (1976) Location of aldosterone-producing adenomas with 131J-19-iodocholesterol. N Engl JMed 294:410–414CrossRefGoogle Scholar
  94. 94.
    Hutter AM, Kayhoe DE (1966) Adrenal cortical carcinoma. Results of treatment with op’ DDD in 138 patients. Am J Med 41:581–592PubMedCrossRefGoogle Scholar
  95. 95.
    Jailer JW, Van de Wiele R, Christy NP, Liebermann S (1959) Studies in Cushing’s syndrome. III. Urinary 17-ketosteroids in patients with bilateral adrenal cortical hyperplasia. J Clin Invest 38:357–365PubMedCrossRefGoogle Scholar
  96. 96.
    James VHT (1961) The excretion of individual 17-oxosteroids in Cushing’s syndrome. J Endocrinol 23:119–127PubMedCrossRefGoogle Scholar
  97. 97.
    James VHT, Landau J, Wynn V (1965) Oral and intravenous suppression tests in the diagnosis of Cushing’s syndrome. J Endocrinol 36: 515–524CrossRefGoogle Scholar
  98. 98.
    Johnson JA, Davis JO, Witty RT (1971) Effect of the catecholamines and renal nerve stimulation on renin release in the nonfiltering kidney. Circ Res 29:646–653PubMedGoogle Scholar
  99. 99.
    Jørgenson H, Norman N, Sundsfjord JA (1975) Scintigraphy with 131J-19-iodocholesterol in adrenal disease. Acta Med Scand 197:345–351CrossRefGoogle Scholar
  100. 100.
    Jørgenson H, Stiris G (1974) Hypertensive crisis followed by adrenocortical insufficiency after unilateral adrenal phlebography in a patient with Cushing’s syndrome. Acta Med Scand 196:141–143CrossRefGoogle Scholar
  101. 101.
    Kahn PC, Kelleher MD, Egdahl RH, Melby JC (1971) Adrenal arteriography and venography in primary aldosteronism. Radiology 101: 71–78PubMedGoogle Scholar
  102. 102.
    Kalsner S (1969) Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta. Circ Res 24:383–395PubMedGoogle Scholar
  103. 103.
    Kaplan NM (1963) Primary aldosteronism with malignant hypertension. N Engl J Med 269: 1282–1286PubMedCrossRefGoogle Scholar
  104. 104.
    Kaplan NM (1967) Hypokalemia in the hypertensive patient. Ann Intern Med 66:1079–1090PubMedGoogle Scholar
  105. 105.
    Kaplan NM (1969) Commentary on incidence of primary aldosteronism: Current estimations based on objective data. Arch Intern Med 123:152–154PubMedCrossRefGoogle Scholar
  106. 106.
    Katz FH (1967) Primary aldosteronism with suppressed plasma renin activity due to bilateral nodular adrenocortical hyperplasia. Ann Intern Med 67:1035–1042PubMedGoogle Scholar
  107. 107.
    Kem DC, Weinberger MH, Mayes DM, Nugent CA (1971) Saline suppression of plasma aldosterone in hypertension. Arch Intern Med 128:380–386PubMedCrossRefGoogle Scholar
  108. 108.
    Kem DC, Weinberger MH, Gomez-Sanchez C, Higgins JR, Kramer NJ (1976) The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension and hyperaldosteronism. J Lab Clin Med 88:261–270PubMedGoogle Scholar
  109. 109.
    Krakoff L (1973) Measurement of plasma renin substrate by radioimmunoassay of angiotensin I: Concentration in syndromes associated with steroid excess. J Clin Endocrinol Metab 37:110–117PubMedCrossRefGoogle Scholar
  110. 110.
    Krakoff, L, Nicolis G, Amsel B (1975) Pathogenesis of hypertension in Cushing’s syndrome. Am J Med 58:216–220PubMedCrossRefGoogle Scholar
  111. 111.
    Krieger DT, Amorosa L, Linick F (1975) Cyproheptadine-induced remission of Cushing’s disease. N Engl J Med 293:893–896PubMedCrossRefGoogle Scholar
  112. 112.
    Laidlaw JC, Yendt ER, Gornall AG (1960) Hypertension caused by renal artery occlusion simulating primary aldosteronism. Metabolism 9:612–623PubMedGoogle Scholar
  113. 113.
    Liddle GW (1960) Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 20:1539–1560PubMedCrossRefGoogle Scholar
  114. 114.
    Liddle GW, Bledsoe T, Coppage WS (1963) A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians 76: 199–213Google Scholar
  115. 115.
    Lieberman LM, Beierwaltes WH, Conn JW, Ansari AN, Nishiyama HN (1971) Diagnosis of adrenal disease by visualization of human adrenal glands with 131J-i9-iodocholesterol. N Engl J Med 285:1387–1393PubMedCrossRefGoogle Scholar
  116. 116.
    Linn JE, Bowdoin B, Farmer A, Meador CK (1967) Observations and comments on failure of dexamethasone suppression. N Engl J Med 277:403–405PubMedCrossRefGoogle Scholar
  117. 117.
    Lufkin EG, Katz FH, Hernán RH (1972) Primary aldosteronism due to hyperplasia of zona glomerulosa: failure of suppression by DOCA or stimulation by angiotensin. Am J Med Sci 264:367–374PubMedCrossRefGoogle Scholar
  118. 118.
    MacGregor RR, Sheagren JN, Lipsett MB, Wolff SM (1969) Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. N Engl J Med 280:1427–1431PubMedCrossRefGoogle Scholar
  119. 119.
    McEnery PT, Gonzalez LL, Martin LW, West CD (1973) Growth and development of children with renal transplants. Use of alternate-day steroid therapy. J Pediatr 83:806–814PubMedCrossRefGoogle Scholar
  120. 120.
    MecKenzie AD, Mcintosh HW (1965) Hyperpig- mentation and pituitary tumor as sequelae of the surgical treatment of Cushing’s syndrome. Am J Surg 110:135–141CrossRefGoogle Scholar
  121. 121.
    Melby JC (1971) Therapeutic possibilities in Cushing’s syndrome. N Engl J Med 285: 288–289PubMedCrossRefGoogle Scholar
  122. 122.
    Melby JC, Dale SL, Wilson TE (1971) 18-Hy- droxy-deoxycorticosterone in human hypertension. Circ. Res (Suppl 2) 28–29:143–152Google Scholar
  123. 123.
    Melby JC, Spark RF, Dale SL, Egdahl RH, Kahn PC (1967) Diagnosis and localization of aldosterone-producing adenomas by adrenal vein catheterization. N Engl J Med 277: 1050–1056PubMedCrossRefGoogle Scholar
  124. 124.
    Mendlowitz M, Gitlow S, Naftchi N (1958) Work of digital vasoconstriction produced by infused norepinephrine in Cushing’s syndrome. J Appl Physiol 13:252–256PubMedGoogle Scholar
  125. 125.
    Michelakis AM, Candle J, Liddle GW (1969) In vitro stimulation of renin production by epinephrine, norepinephrine, and cyclic AMP. Proc Soc Exp Biol Med 130:748–753PubMedGoogle Scholar
  126. 126.
    Miura K, Aida M, Mihara A, Kato K, Ojima M, Demura R, Demura H, Okuyama M (1975) Treatment of Cushing’s disease with reserpine and pituitary irradiation. J Clin Endocrinol Metab 41:511–526PubMedCrossRefGoogle Scholar
  127. 127.
    Moore TJ, Dluhy RG, Williams GH, Cain JP (1976) Nelson’s syndrome: Frequency, prognosis and effect of prior pituitary irradiation. Ann Intern Med 85:731–734PubMedGoogle Scholar
  128. 128.
    Müller J, Barajas L (1972) Electron microscopic and histochemical evidence for a tubular inner- vation in the renal cortex of the monkey. J Ultrastruct Res 41:533–549PubMedCrossRefGoogle Scholar
  129. 129.
    Nelson DH, Meakin JW, Dealy JB (1958) ACTH-producing tumor of the pituitary gland. N Engl JMed 259:161–164CrossRefGoogle Scholar
  130. 130.
    Neville AM, Symington T (1966) Pathology of primary aldosteronism. Cancer 19:1854–1868PubMedCrossRefGoogle Scholar
  131. 131.
    New MI (1970) Male pseudohermaphroditism due to 17-hydroxylase deficiency. J Clin Invest 49:1930–1941PubMedCrossRefGoogle Scholar
  132. 132.
    Newton MA, Laragh JH (1968) Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism. J Clin Endocrinol Metab 28:1014–1022PubMedCrossRefGoogle Scholar
  133. 133.
    Ng KKF, Vane JR (1967) Conversion of angiotensin I to angiotensin II. Nature 216:762–766PubMedCrossRefGoogle Scholar
  134. 134.
    Ng KKF, Vane JR (1970) Some properties of angiotensin converting enzyme in the lung in vivo. Nature 225:1142–1144PubMedCrossRefGoogle Scholar
  135. 135.
    Nicholls MG, Espiner EA, Hughes A, Ross J, Stewart DT (1975) Primary aldosteronism. A study in contrast. Am J Med 59:334–342PubMedCrossRefGoogle Scholar
  136. 136.
    Nichols T, Nugent CA, Tyler FH (1968) Steroid laboratory tests in the diagnosis of Cushing’s syndrome. Am J Med 45:116–128CrossRefGoogle Scholar
  137. 137.
    Nicolis GL, Mitty HA, Modlinger RS, Gabrilove JL (1972) Percutaneous adrenal venography. A clinical study of 50 patients. Ann Intern Med 76:899–909PubMedGoogle Scholar
  138. 138.
    Nicolis GL, Babich AM, Mitty HA, Gabrilove LJ (1974) Observation on the Cortisol content of human adrenal venous blood. J Clin Endocrinol Metab 38:638–645PubMedCrossRefGoogle Scholar
  139. 139.
    Nilsson O (1965) The adrenergic innervation of the kidney. Lab Invest 14:1392–1395PubMedGoogle Scholar
  140. 140.
    Nugent CA, Nichols T (1965) Diagnosis of Cushing’s syndrome. Arch Intern Med 116: 172–176PubMedCrossRefGoogle Scholar
  141. 141.
    Nugent CA, Warner HR, Dunn JT, Tyler FH (1964) Probability theory in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 24:621–627PubMedCrossRefGoogle Scholar
  142. 142.
    Oddie CJ, Coghlan JP, Scoggins BA (1979) Plasma deoxycorticosterone levels in man with simultaneous measurement of aldosterone, corticosterone, Cortisol and 11-deoxycortisol. J Clin Endocrinol Metab 34:1039–1054CrossRefGoogle Scholar
  143. 143.
    Ø1gaard K (1975) Plasma aldosterone in anephric and non-nephrectomized dialysis patients in relation to changes in plasma potassium without change in total potassium balance. Acta Med Scand 198:213–218PubMedCrossRefGoogle Scholar
  144. 144.
    01gaard K, Madson S, Hammer M (1977) The adrenocortical response to angiotensin II infusion in anephric and non-nephrectomized patients on regular hemodialysis. Acta Med Scand 202:213–219PubMedCrossRefGoogle Scholar
  145. 145.
    O’Neal LW, Kissane JM, Hartroft PM, Louis S (1970) The kidney in endocrine hypertension. Arch Surg 100:498–505PubMedCrossRefGoogle Scholar
  146. 146.
    Orth DN, Liddle GW (1971) Results of treatment in 108 patients with Cushing’s disease. N Engl JMed 285:244–247CrossRefGoogle Scholar
  147. 147.
    Padfield PL, Allison MEM, Brown JJ, Ferris JB, Fräser R, Lever AF, Luke RG, Robertson JIS (1975) Response of plasma aldosterone to fludrocortisone in primary hyperaldosteronism and other forms of hypertension. Clin Endocrinol (Oxf) 4:493–500CrossRefGoogle Scholar
  148. 148.
    Page IH, Helmer OM (1940) A crystalline pressure substance (angiotensin) resulting from the reaction between renin and renin activator. J Exp Med 71:29–42PubMedCrossRefGoogle Scholar
  149. 149.
    Pearse AGE (1969) The cytochemistry and ul- trastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 17:303–313PubMedCrossRefGoogle Scholar
  150. 150.
    Poulson K, Burton J, Haber E (1973) Competitive inhibitors of renin. Biochemistry 12: 3877–3882CrossRefGoogle Scholar
  151. 151.
    Ragan C (1953) Corticotropin, cortisone and related steroids in clinical medicine. Bull N Y Acad Med 29:355–376PubMedGoogle Scholar
  152. 152.
    Reed WP, Lucas ZJ, Cohn R (1970) Alternate- day prednisone therapy after renal transplantation. Lancet 1:747–749PubMedCrossRefGoogle Scholar
  153. 153.
    Reuter SR, Blair AJ, Schteingart DE, Bookstein JJ (1967) Adrenal venography. Radiology 89:805–814PubMedGoogle Scholar
  154. 154.
    Romero JC, Hoobler SW, Kozak TJ, Warzynski RJ (1973) Effect of antirenin on blood pressure of rabbits with experimental renal hypertension. Am J Physiol 225:810–817PubMedGoogle Scholar
  155. 155.
    Ross EJ, Marshall-Jones P, Friedman M (1966) Cushing’s syndrome: Diagnostic criteria. Q J Med 35:149–193PubMedGoogle Scholar
  156. 156.
    Rosset E, Veyrat R (1971) Release of renin by human kidney shces: in vitro effect of angiotensin II, norepinephrine and aldosterone. Rev Eur Etulin Biol 16:792–794Google Scholar
  157. 157.
    Ryan JW (1967) Renin-like enzyme in the adrenal gland. Science 158:1589–1590PubMedCrossRefGoogle Scholar
  158. 158.
    Salti IS, Stiefel M, Ruse JL, Laidlaw JC (1969) Non-tumorous „primary” aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid- remidiable aldosteronism). Can Med Assoc J 101:1–10PubMedGoogle Scholar
  159. 159.
    Sarkar SD, Beierwaltes WH, Ice RD, Besmadjian GP, Hetzel KR, Kennedy WP, Mason MM (1975) A new and superior adrenal scanning agent, NP-59. J Nucl Med Allied Sci 16: 1038–1042Google Scholar
  160. 160.
    Schambelan M, Brust NL, Chang CF, Slater KL, Biglieri EG (1976) Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J Clin Endocrinol Metab 43:115–131PubMedCrossRefGoogle Scholar
  161. 161.
    Schambelan M, Slaton PE, Biglieri EG (1971) Mineralocorticoid production in hyperadreno- corticism. Role in pathogenesis of hypokalemic alkalosis. Am J Med 51:299–303PubMedCrossRefGoogle Scholar
  162. 162.
    Scoggins BA, Oddie CJ, Hare WSC, Coghlan JP (1972) Preoperative latéralisation of aldoster- one-producing tumors in primary aldosteronism. Ann Intern Med 76:891–897PubMedGoogle Scholar
  163. 163.
    Scott HW, Liddle GW, Harris AP, Förster JH (1962) Diagnosis and treatment of Cushing’s syndrome. Ann Surg 155:696–710CrossRefGoogle Scholar
  164. 164.
    Seabold JE, Cohen EL, Beierwaltes WH, Hinerman DL, Nishiyama RH, Bookstein JJ, Ice RD, Balachandran S (1976) Adrenal imaging with 131J-19-iodocholesterol in the diagnostic evaluation of patients with primary aldosteronism. J Clin Endocrinol Metab 42:41–51PubMedCrossRefGoogle Scholar
  165. 165.
    Sederberg-Olsen P, Binder Ch, Kehlet H, Neville AM, Nielsen LM (1973) Episodic variation in plasma corticosteroids in subjects with Cushing’s syndrome of differing ethiology. J Clin Endocrin Metab 36:906–910CrossRefGoogle Scholar
  166. 166.
    Shade RE, Davis JO, Johnson JA, Witty RT (1972) Effects of renal arterial infusion of sodium and potassium on renin secretion in the dog. Circ Res 31:719–727PubMedGoogle Scholar
  167. 167.
    Siegel RR, Luke RG, Hellebusch AA (1972) Reduction of toxicity of corticosteroid therapy after renal transplantation. Am J Med 53: 159–169PubMedCrossRefGoogle Scholar
  168. 168.
    Slaton PE, Schambelan M, Biglieri EG (1969) Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma. J Clin Endocrinol Metab 29:239–250PubMedCrossRefGoogle Scholar
  169. 169.
    Soyka LF (1967) Treatment of the nephrotic syndrome in childhood. Use of an alternate-day prednisone regimen. Am J Dis Child 113: 693–701PubMedGoogle Scholar
  170. 170.
    Spark RF, Kettyle WR, Eisenberg H (1974) Cortisol dynamics in the adrenal venous effluent. J Clin Endocrinol Metab 39:305–310PubMedCrossRefGoogle Scholar
  171. 171.
    Starer F (1965) Percutaneous supraadrenal venography. Br J Radiol 38:675–681PubMedCrossRefGoogle Scholar
  172. 172.
    Streeten DHP, Stevenson CT, Dalakos TG, Nicholas JJ, Dennick LG, Fellerman H (1969) The diagnosis of hypercortisolism. Biochemical criteria differentiating patients from lean and obese normal subjects and from females on oral contraceptives. J Clin Endocrinol Metab 29:1191–1211PubMedCrossRefGoogle Scholar
  173. 173.
    Tagawe H, Vander AJ, Bonjour JP, Malvin RL (1971) Inhibition of renin secretion by vasopressin in anesthetized sodium-deprived dogs. Am J Physiol 220:949–951Google Scholar
  174. 174.
    Taylor HC, Sachs CR, Bravo EL (1976) Primary aldosteronism: Remission and development of adrenal insufficiency after adrenal venography. Ann Intern Med 85:207–209PubMedGoogle Scholar
  175. 175.
    Thurau K, Dahlheim H, Grüner A, Mason J, Granger P (1979) Activation of renin in the single juxtaglomerular apparatus by sodium chloride in the tubular fluid at the macula densa. Circ Res (Suppl 2) 30:182–186Google Scholar
  176. 176.
    Tigerstedt R, Bergman PG (1898) Niere und Kreislauf. Scand Arch Physiol 8:223–271Google Scholar
  177. 177.
    Tobian L, Tomboulian A, Janacek J (1959) The effect of high perfusion pressures on the granulation of juxtaglomerular cells in an isolated kidney. J Clin Invest 38:605–610PubMedCrossRefGoogle Scholar
  178. 178.
    Todesco S, Terrible V, Borsatti A, Mantero F (1975) Primary aldosteronism due to a malignant ovarian tumor. J CHn Endocrinol Metab 41:809–819CrossRefGoogle Scholar
  179. 179.
    Tourniaire J, Orgiazzi J, Riviere JF, Rousset H (1971) Repeated plasma Cortisol determinations in Cushing’s syndrome due to adrenocortical adenoma. J Clin Endocrinol Metab 32:666–668PubMedCrossRefGoogle Scholar
  180. 180.
    Vander AJ (1965) Effect of catecholamines and renal nerves on renin secretion in anesthetized dogs. Am J Physiol 209:659–662PubMedGoogle Scholar
  181. 181.
    Vander AJ, Miller R (1964) Control of renin secretion in the anesthetized dog. Am J Physiol 207:537–546PubMedGoogle Scholar
  182. 182.
    Velayos EE, Leidholt JD, Smyth CJ, Priest R (1966) Arthropathy associated with steroid therapy. Ann Intern Med 64:759–771Google Scholar
  183. 183.
    Vetter H, Berger M, Armbruster H, Siegenthaler W, Werning C, Vetter W (1974) Episodic secretion of aldosterone in primary aldosteronism: Relationship to Cortisol. Clin Endocrinol (Oxf) 3:41–48CrossRefGoogle Scholar
  184. 184.
    Vetter H, Strass R, Bayer J-M, Beckerhoff R, Armbruster H, Vetter W (1977) Short-term fluctuations in plasma Cortisol in Cushing’s syndrome. Clin Endocrinol (Oxf) 6:1–4CrossRefGoogle Scholar
  185. 185.
    Vetter H, Vetter W (1975) Regulation of aldosterone secretion in primary aldosteronism. Horm Metab Res 7:418–424PubMedCrossRefGoogle Scholar
  186. 186.
    Vetter H, Vetter W, Beckerhoff R, Sobbe A, Nußberger J, Witassek F, Siegenthaler W (1975) Primärer Aldosteronismus: Diagnose, Seitenlokalisation und Regulation der Hormonsekretion. Schweiz Med Wochenschr 105: 1695–1698PubMedGoogle Scholar
  187. 187.
    Vetter W, Vetter H, Nußberger J, Witassek F, Beckerhoff R, Pouliadis G, Braun KP, Sobbe A, Furrer J, Siegenthaler W (1976) Primärer Aldosteronismus. Schweiz Med Wochenschr 106:469–474PubMedGoogle Scholar
  188. 188.
    Vetter W, Vetter H, Beckerhoff R, Würsten D, Siegenthaler W (1976) Nicht dauerhafte Remission des Hyperkortizismus durch Cyproheptadin bei einer Patientin mit Cushing-Syndrom. Schweiz Med Wochenschr 106:1320–1322PubMedGoogle Scholar
  189. 189.
    Vetter W, Vetter H, Beckerhoff R, Witassek F, Pouliadis G, Furrer J, Siegenthaler W (1976) Endokrine Hypertonie bei primärem Aldosteronismus und Cushing-Syndrom. Schweiz Med Wochenschr 106:1773–1777PubMedGoogle Scholar
  190. 190.
    Vetter W, Zäruba K, Armbruster H, Beckerhoff R, Reck G, Siegenthaler W (1974) Control of plasma aldosterone in supine anephric man. Clin Endocrinol (Oxf) 3:411–419CrossRefGoogle Scholar
  191. 191.
    Vetter W, Zaruba K, Armbruster H, Beckerhoff R, Uhlschmid G, Furrer J, Siegenthaler W (1976) Control of plasma aldosterone in terminal renal failure before and after nephrectomy and after renal transplantation. Clin Nephrol 6:433–436PubMedGoogle Scholar
  192. 192.
    Veyrat R, Brunner HR, Manning EL, Muller AF (1967) Inhibition de l’activité de la rénine plasmatique par le potassium. J Urol Nephrol (Paris) 73:271–275Google Scholar
  193. 193.
    Wakerlin GE (1958) Antibodies to renin as proof of the pathogenesis of sustained renal hypertension. Circulation 17:653–657PubMedGoogle Scholar
  194. 194.
    Walker AE, Adamkiewicz JJ (1964) Pseudotumor cerebri associated with prolonged corticosteroid therapy. JAMA 188:779–784PubMedCrossRefGoogle Scholar
  195. 195.
    Weichert RF (1970) The neural ectodermal origin of the peptide secreting endocrine glands. Am J Med 49:232–241PubMedCrossRefGoogle Scholar
  196. 196.
    Weiss FR, Rayyis SS, Nelson DH, Bethune JE (1969) Evaluation of stimulation and suppression tests in the ethiological diagnosis of Cushing’s syndrome. Ann Intern Med 71:941–949PubMedGoogle Scholar
  197. 197.
    Weming C, Stadelmann O, Miederer SE, Vetter W, Schweikert HU, Stiel D, Siegenthaler W (1971) Der Einfluß einer Carbenoxolon-Thera- pie auf das Renin-Angiotensin-Aldosteron-Sy- stem. Klin Wochenschr 49:1285–1289CrossRefGoogle Scholar
  198. 198.
    Wogermark J, Ungerstedt U, Ljungvist A (1968) Sympathetic innervation of the juxtaglomerular cells of the kidney. Circ Res 22: 149–153Google Scholar
  199. 199.
    Woods JW, Hill Ch, Liddle GW, Stant EG, Michelakis AM, Brill AB (1969) Effect of an adrenal inhibitor in hypertensive patients with suppressed renin. Arch Intern Med 123:366–370PubMedCrossRefGoogle Scholar
  200. 200.
    Yune HY, Klatte EC, Grim CE, Weinberger MH, Donohue JP, Yum MN, Wellman HN (1976) Radiology in primary aldosteronism. AJR 127:761–767PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • Hans Vetter
  • Wilhelm Vetter

There are no affiliations available

Personalised recommendations